A 52-year-old man with type 2 diabetes (HbA1c 8.3 percent), BMI 35 kg/m², and established atherosclerotic cardiovascular disease is already on metform...

Question

A 52-year-old man with type 2 diabetes (HbA1c 8.3 percent), BMI 35 kg/m², and established atherosclerotic cardiovascular disease is already on metformin and a statin. According to Diabetes Canada, which additional antihyperglycaemic agent provides the greatest cardiovascular benefit?

Accepted Answer

SGLT2 inhibitor

Answer

Sulfonylurea

Answer

DPP-4 inhibitor

Answer

Basal insulin

Answer

Acarbose

ca-mccqe1 MCQ (SBA): Type 2 diabetes with ASCVD

A 52-year-old man with type 2 diabetes (HbA1c 8.3 percent), BMI 35 kg/m², and established atherosclerotic cardiovascular disease is already on metformin and a statin. According to Diabetes Canada, which additional antihyperglycaemic agent provides the greatest cardiovascular benefit?